Risk of Venous Thromboembolism with Selective Estrogen Receptor Modulators for Postmenopausal Osteoporosis: A Meta-Analysis of Randomized Trials Program

Authors

Rashmi Dhital, Reading Hospital-Tower HealthFollow
Anthony A. Donato, Reading Hospital-Tower HealthFollow
Bidhya Timilsina, Reading Hospital
Theresa Lynn, Reading Hospital-Tower Health
Colin Peters, Reading Hospital-Tower Health
Oreoluwa Oladiran, Reading Hospital-Tower Health
Prem Raj Parajuli, Reading Hospital-Tower Health
Prakash Paudel, Berkshire Medical Center

Document Type

Poster Presentation

Publication Date

10-23-2018

Publication Title

Arthritis and Rheumatology

Volume

70

Issue

10 Supplement

Comments

American College of Rheumatology
2018 ACR/ARHP Annual Meeting

ABSTRACT NUMBER: 2813

Recommended Citation

Dhital, R., Donato, A. A., Timilsina, B., Lynn, T., Peters, C., Oladiran, O., Parajuli, P., & Paudel, P. (2018). Risk of Venous Thromboembolism with Selective Estrogen Receptor Modulators for Postmenopausal Osteoporosis: A Meta-Analysis of Randomized Trials Program. Arthritis and Rheumatology, 70 (10 Supplement) Retrieved from https://scholarcommons.towerhealth.org/gme_int_med_resident_program_read/132